TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you purchased shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Mirati Therapeutics, Inc.
Security
NASDAQ: MRTX

Summary

June 13, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Mirati Therapeutics, Inc. (NASDAQ:MRTX) shares over potential securities laws violations in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Mirati Therapeutics, Inc. (NASDAQ:MRTX) concerning whether a series of statements regarding Mirati Therapeutics business, its prospects and its operations were materially false and misleading at the time they were made.

Shares of Mirati Therapeutics, Inc .(NASDAQ:MRTX) reached as high as $43.57 per share in September 2015.

On June 5, 2016, Mirati Therapeutics, Inc. provided an update on three current ongoing clinical programs in patients with non-small cell lung cancer (NSCLC) and other solid tumors.

Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) declined from as high as $19.25 per share on June 3, 2016, to as low as $9.11 per share on June 8, 2016.

Start Monitoring Your Investments